Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Behaviour Research and Therapy|April 4, 2007
Does magical thinking produce neutralising behaviour? An experimental investigationLaura Bocci, P Kenneth GordonImmunotherapy|March 20, 2024
Bimekizumab for the treatment of psoriasisMolly Thapar, Milan Patel, Kenneth GordonThe Lancet. Rheumatology|January 22, 2024
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort studyShikha Singla, Michael Putman, Jean Liew, et al.Journal of the American Academy of Dermatology|June 22, 2016
Serious infections in hospitalized patients with psoriasis in the United StatesDerek Y Hsu, Kenneth Gordon, Jonathan I SilverbergJournal of the American Academy of Dermatology|May 24, 2016
The inpatient burden of psoriasis in the United StatesDerek Y Hsu, Kenneth Gordon, Jonathan I SilverbergACS Omega|April 6, 2026
Automated Multi-Scale Morphometry Analysis of Fibrous NetworksSandesh Giri, Kenneth Gordon, Karson Vidrine, et al.Journal of the American Academy of Dermatology|July 15, 2011
Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: results from an open-label extension study for patients from REVEALKenneth Gordon, Kim Papp, Yves Poulin, et al.The Journal of Allergy and Clinical Immunology|November 12, 2021
Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasisIan M Catlett, Yanhua Hu, Lu Gao, et al.Journal of the American Academy of Dermatology|February 21, 2006
Efficacy of etanercept in an integrated multistudy database of patients with psoriasisKenneth Gordon, Neil Korman, Ellen Frankel, et al.The Journal of Dermatological Treatment|March 31, 2015
The experience of pain and redness in patients with moderate to severe plaque psoriasisMona L Martin, Kenneth Gordon, Lionel Pinto, et al.Pageof 4